Cargando…
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
The azanucleosides azacitidine and decitabine are currently used for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in patients not only eligible for intensive chemotherapy but are also being explored in other hematologic and solid cancers. Based on their capacity...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915187/ https://www.ncbi.nlm.nih.gov/pubmed/27330573 http://dx.doi.org/10.1186/s13148-016-0237-y |